八正散加减治疗氯胺酮性膀胱炎疗效观察  

Clinical Observation of Modified Bazheng Powder for Treatment of Ketamine-associated Cystitis

作　　者：王宇雄[1,2] 刘春晓[1] 姜成龙 谢小平 

机构地区：[1]南方医科大学附属珠江医院泌尿外科,广东广州510282 [2]广东省中西医结合医院泌尿外科,广东佛山528200

出　　处：《新中医》2014年第1期88-90,共3页New Chinese Medicine

基　　金：广东省中医药局科研基金项目(编号:20111147)

摘　　要：目的:观察八正散加味治疗氯胺酮性膀胱炎的临床疗效。方法:将21例患者随机分为观察组11例和对照组10例,观察组采用八正散加味治疗,对照组服用酒石酸托特罗定,观察比较2组治疗前后O’Leary-Sant问卷表中问题评分(ICP)I、症状评分(ICS)I、日间排尿次数及夜间排尿次数。结果:治疗后2组ICPI评分、ICSI评分、日间排尿次数、夜间排尿次数等指标均比治疗前明显改善,差异均有显著性意义(P<0.05);观察组各项指标改善较对照组更为显著(P<0.05)。结论:八正散加味能显著提高氯胺酮性膀胱炎患者的临床疗效。Objective： To investigate the clinical curative effect of modified Bazheng powder for the treatment of ketamine-associated cystitis. Methods： Twenty-one ketamine-associated cystitis patients were randomly divided into observation group（n=11） and control group（n=10）. The patients of observation group were treated with modified Bazheng powder, and the control group was given tolterodine tartrate tablets. Before and after treatment, the scores of interstitial cystitis problem index（ICPI） and interstitial cystitis symptom index（ICSI） of O＇Leary-Sant scale, daytime urination frequency and nighttime urination frequency were monitored in the two groups. Results： The scores of ICPI and ICSI as well as the fre quency of daytime and nighttime urination were improved in the two groups after treatment（P 〈 0.05 com- pared with those before treatment）, and the improvement in the observation group was superior to that in the control group（P 〈 0.05）. Conclusion- Modified Bazheng powder has certain effect for the treatment of ketamine-associated cystitis.

关 键 词：膀胱炎 氯胺酮 八正散 

分 类 号：R694.3[医药卫生—泌尿科学]